Skip to main content
SpringerLink
Log in

The BEAUTIFUL study: Is heart rate reduction a new therapeutic principle?

  • Clinical Trials Report
  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Fox K, Ford I, Steg PG, et al.; BEAUTIFUL Investigators: Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet 2008, 372:807–816.

    Article  PubMed  CAS  Google Scholar 

  2. Fox K, Ford I, Steg PG, et al.; BEAUTIFUL Investigators: Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet 2008, 372:817–821.

    Article  PubMed  Google Scholar 

  3. Kjekshus JK: Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol 1986, 57:43F–49F.

    Article  PubMed  CAS  Google Scholar 

  4. Kjekshus J, Gullestad L: Heart rate as a therapeutic target in heart failure. Eur Heart J 1999, 1(Suppl H):H64–H69.

    Google Scholar 

  5. Palatini P, Benetos A, Grassi G, et al.: Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting. J Hypertens 2006, 24:603–610.

    Article  PubMed  CAS  Google Scholar 

  6. Levy RL, White PD, Stroud WD: Transient tachycardia: prognostic significance alone and in association with transient hypertension. JAMA 1945, 129:585–588.

    Google Scholar 

  7. Dyer AR, Persky V, Stamler J, et al.: Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol 1980, 112:736–749.

    PubMed  CAS  Google Scholar 

  8. Kannel WB, Kannel C, Paffenbarger RS Jr, Cupples LA: Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 1987, 113:1489–1494.

    Article  PubMed  CAS  Google Scholar 

  9. DiFrancesco D, Camm JA: Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease. Drugs 2004, 64:1757–1765.

    Article  PubMed  CAS  Google Scholar 

  10. Fox K, Garcia MA, Ardissino D, et al.: Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 2006, 27:1341–1381.

    Article  PubMed  Google Scholar 

  11. Cohn JN, Levine TB, Olivari MT, et al.: Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984, 311:819–823.

    PubMed  CAS  Google Scholar 

  12. Diaz A, Bourassa MG, Guertin MC, Tardif JC: Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 2005, 26:967–974.

    Article  PubMed  Google Scholar 

  13. Kolloch R, Legler UF, Champion A, et al.: Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST). Eur Heart J 2008, 29:1327–1334.

    Article  PubMed  Google Scholar 

  14. Fox K, Borer JS, Camm AJ, et al.: Resting heart rate in cardiovascular disease. J Am Coll Cardiol 2007, 50:823–830.

    Article  PubMed  Google Scholar 

  15. Giannoglou GD, Chatzizisis YS, Zamboulis C, et al.: Elevated heart rate and atherosclerosis: an overview of the pathogenetic mechanisms. Int J Cardiol 2008, 126:302–312.

    Article  PubMed  Google Scholar 

  16. Heidland UE, Strauer BE: Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption. Circulation 2001, 104:1477–1482.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Frank Enseleit
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Frank T. Ruschitzka
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Enseleit, F., Ruschitzka, F.T. The BEAUTIFUL study: Is heart rate reduction a new therapeutic principle?. Current Science Inc 11, 45–47 (2009). https://doi.org/10.1007/s11906-009-0009-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-009-0009-6

Keywords

Search

Navigation